Concert Pharmaceuticals, Inc.
DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
Last updated:
Abstract:
This invention relates to methods of treating agitation comprising administering a morphinan compound or a pharmaceutically acceptable salt thereof. This invention also provides the use in methods of treating agitation and related disorders with such a morphinan compound in combination with quinidine, or pharmaceutically acceptable salt of either or both thereof.
Status:
Application
Type:
Utility
Filling date:
22 Jul 2019
Issue date:
7 Nov 2019